Bioamber Stock Price, News & Analysis (NYSE:BIOA)

$0.07 +0.01 (+9.37 %)
(As of 02/19/2018 04:00 PM ET)
Previous Close$0.06
Today's Range$0.05 - $0.08
52-Week Range$0.05 - $3.74
Volume4.71 million shs
Average Volume3.40 million shs
Market Capitalization$1.41 million
P/E Ratio-0.10
Dividend YieldN/A
Beta2.52

About Bioamber (NYSE:BIOA)

Bioamber logoBioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Receive BIOA News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:BIOA
CUSIPN/A
Phone+1-612-7474423

Debt

Debt-to-Equity Ratio0.24%
Current Ratio1.08%
Quick Ratio0.75%

Price-To-Earnings

Trailing P/E Ratio-0.0984285714285714
Forward P/E Ratio-0.13
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.27 million
Price / Sales0.43
Cash FlowN/A
Price / CashN/A
Book Value$1.41 per share
Price / Book0.05

Profitability

Trailing EPS($0.70)
Net Income$-22,470,000.00
Net Margins-238.43%
Return on Equity-48.72%
Return on Assets-22.92%

Miscellaneous

Employees86
Outstanding Shares52,010,000

Bioamber (NYSE:BIOA) Frequently Asked Questions

What is Bioamber's stock symbol?

Bioamber trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIOA."

How were Bioamber's earnings last quarter?

Bioamber Inc (NYSE:BIOA) issued its quarterly earnings results on Tuesday, August, 9th. The biotechnology company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.02. The biotechnology company had revenue of $2.50 million for the quarter, compared to the consensus estimate of $2.37 million. Bioamber had a negative net margin of 238.43% and a negative return on equity of 48.72%. View Bioamber's Earnings History.

When will Bioamber make its next earnings announcement?

Bioamber is scheduled to release their next quarterly earnings announcement on Thursday, March, 15th 2018. View Earnings Estimates for Bioamber.

Where is Bioamber's stock going? Where will Bioamber's stock price be in 2018?

2 brokers have issued 12 month price targets for Bioamber's stock. Their predictions range from $1.00 to $12.00. On average, they expect Bioamber's share price to reach $6.50 in the next twelve months. View Analyst Ratings for Bioamber.

Who are some of Bioamber's key competitors?

Who are Bioamber's key executives?

Bioamber's management team includes the folowing people:

  • Raymond J. Land, Chairman of the Board (Age 72)
  • Richard P. Eno, Chief Financial Officer, Director
  • Mario Settino, Chief Financial Officer
  • Michael A. Hartmann, Executive Vice President (Age 48)
  • James Millis, Chief Technology Officer (Age 59)
  • Robert Frost, Director
  • Kurt W. Briner, Independent Director (Age 70)
  • Heinz Haller, Independent Director (Age 62)
  • Ellen B. Richstone, Independent Director (Age 65)
  • Kenneth W Wall, Independent Director (Age 66)

How do I buy Bioamber stock?

Shares of Bioamber can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bioamber's stock price today?

One share of Bioamber stock can currently be purchased for approximately $0.07.

How big of a company is Bioamber?

Bioamber has a market capitalization of $3.58 million and generates $8.27 million in revenue each year. The biotechnology company earns $-22,470,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis. Bioamber employs 86 workers across the globe.

How can I contact Bioamber?

Bioamber's mailing address is 1250 Rene Levesque West Suite 4310, Montreal A8, H3B 4W8. The biotechnology company can be reached via phone at 514-844-8000 or via email at [email protected]


MarketBeat Community Rating for Bioamber (BIOA)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  225
MarketBeat's community ratings are surveys of what our community members think about Bioamber and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bioamber (NYSE:BIOA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.672.672.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.50$6.50$6.50$3.00
Price Target Upside: 1,429.41% upside1,429.41% upside1,429.41% upside13.64% upside

Bioamber (NYSE:BIOA) Consensus Price Target History

Price Target History for Bioamber (NYSE:BIOA)

Bioamber (NYSE:BIOA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2017CowenReiterated RatingHold$1.00N/AView Rating Details
11/8/2017HC WainwrightReiterated RatingBuy$12.00N/AView Rating Details
3/13/2017AltaCorp CapitalDowngradeOutperform -> SpeculativeMediumView Rating Details
8/7/2016Canaccord GenuityReiterated RatingBuy$5.50N/AView Rating Details
3/28/2016Credit Suisse GroupBoost Price TargetOutperform$15.00 -> $17.00N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Bioamber (NYSE:BIOA) Earnings History and Estimates Chart

Earnings by Quarter for Bioamber (NYSE:BIOA)

Bioamber (NYSE BIOA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2018N/AView Earnings Details
11/7/2017Q3 2017($0.21)$3.30 millionViewN/AView Earnings Details
8/3/20176/30/2017($0.17)($0.20)$4.09 million$4.12 millionViewListenView Earnings Details
5/9/20173/31/2017($0.13)($0.31)$3.65 million$2.12 millionViewListenView Earnings Details
3/16/201712/31/2016($0.19)($0.31)$3.77 million$0.63 millionViewN/AView Earnings Details
11/3/2016Q216($0.22)($0.26)$3.75 million$3.66 millionViewN/AView Earnings Details
8/9/2016Q116($0.27)($0.25)$2.37 million$2.50 millionViewN/AView Earnings Details
5/3/2016Q1 2016($0.07)($0.29)$2.25 million$1.46 millionViewN/AView Earnings Details
3/14/2016Q415($0.35)($0.40)$0.98 million$1.11 millionViewN/AView Earnings Details
11/4/2015Q315($0.41)($0.27)$2.30 million$0.35 millionViewN/AView Earnings Details
8/4/2015Q2 2015($0.39)$0.34 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.39)$0.37 millionViewN/AView Earnings Details
3/12/2015Q414($0.39)($0.48)($0.31) millionViewN/AView Earnings Details
11/6/2014Q3 2014($0.40)($0.41)$0.47 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.40)$0.40$0.45 million$0.42 millionViewN/AView Earnings Details
5/8/2014Q1 2014$0.45$0.35 millionViewN/AView Earnings Details
3/13/2014($0.36)($0.45)$0.44 millionViewListenView Earnings Details
11/7/2013Q3 2013($0.37)$0.87 millionViewN/AView Earnings Details
8/12/2013Q2 2013$0.57$1.03 millionViewN/AView Earnings Details
5/15/2013Q1 2013$0.92$0.33 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Bioamber (NYSE:BIOA) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.53 EPS
Next Year EPS Consensus Estimate: $-0.28 EPS

Dividends

Dividend History for Bioamber (NYSE:BIOA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Bioamber (NYSE BIOA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.33%
Institutional Ownership Percentage: 28.70%
Insider Trades by Quarter for Bioamber (NYSE:BIOA)
Institutional Ownership by Quarter for Bioamber (NYSE:BIOA)

Bioamber (NYSE BIOA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2017Kenneth W WallDirectorBuy40,000$0.43$17,200.00170,443View SEC Filing  
8/18/2017Michael A HartmannInsiderBuy10,000$0.48$4,800.00153,476View SEC Filing  
8/9/2017Mario SettinoCFOBuy15,000$0.53$7,950.0030,000View SEC Filing  
11/9/2016George Frederick John GosbeeDirectorBuy25,000$3.87$96,750.0025,000View SEC Filing  
11/8/2016Kurt W BrinerDirectorBuy10,000$3.84$38,400.00152,645View SEC Filing  
5/24/2016Kurt W BrinerDirectorBuy1,000$3.69$3,690.00142,645View SEC Filing  
5/23/2016Kurt W BrinerDirectorBuy21,015$3.61$75,864.15132,730View SEC Filing  
5/11/2016Jean-Francois HucCEOBuy10,000$3.22$32,200.00154,222View SEC Filing  
5/9/2016Kenneth W WallDirectorBuy13,227$3.11$41,135.9731,227View SEC Filing  
5/6/2016Michael A HartmannEVPBuy3,000$3.44$10,320.00125,143View SEC Filing  
12/3/2015Jean-Francois HucCEOSell27,278$8.11$221,224.58144,222View SEC Filing  
12/3/2015Michael A. HartmannEVPSell21,477$8.11$174,178.47123,143View SEC Filing  
8/14/2015Michael A HartmannEVPBuy1,500$6.75$10,125.00View SEC Filing  
8/11/2015Jean-Francois HucCEOBuy4,000$6.18$24,720.00View SEC Filing  
8/10/2015Raymond J LandDirectorBuy1,500$6.71$10,065.00View SEC Filing  
5/6/2015Jean-Francois HucCEOBuy8,800$9.00$79,200.00View SEC Filing  
5/6/2015Kurt W BrinerDirectorBuy10,000$9.00$90,000.00View SEC Filing  
5/6/2015Michael A HartmannEVPBuy1,100$9.00$9,900.00View SEC Filing  
12/11/2014Kenneth W WallDirectorBuy3,000$9.20$27,600.00View SEC Filing  
12/10/2014Kenneth W WallDirectorBuy5,000$9.30$46,500.00View SEC Filing  
11/10/2014Kurt W BrinerDirectorBuy15,000$9.35$140,250.00View SEC Filing  
9/9/2014Kurt W BrinerDirectorBuy5,000$12.00$60,000.00View SEC Filing  
8/25/2014Kurt W BrinerDirectorBuy14,250$11.50$163,875.00View SEC Filing  
8/11/2014Kurt W BrinerDirectorBuy2,980$11.45$34,121.00View SEC Filing  
7/16/2014Jean-Francois HucCEOBuy4,000$12.00$48,000.00View SEC Filing  
7/16/2014Michael A HartmannEVPBuy3,000$12.00$36,000.00View SEC Filing  
5/12/2014Andrew P AshworthCFOBuy3,000$10.00$30,000.00View SEC Filing  
5/12/2014Michael A HartmannEVPBuy2,500$10.05$25,125.00View SEC Filing  
11/14/2013Kurt W BrinerDirectorBuy7,200$6.95$50,040.00View SEC Filing  
9/3/2013Michael A HartmannEVPBuy2,000$4.63$9,260.00View SEC Filing  
8/29/2013Jean-Francois HucCEOBuy5,000$4.25$21,250.00View SEC Filing  
8/15/2013Kurt W BrinerDirectorBuy13,000$5.49$71,370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bioamber (NYSE BIOA) News Headlines

Source:
DateHeadline
BioAmber Inc. Receives Notice of Delisting by TSX - PR Newswire (press release)BioAmber Inc. Receives Notice of Delisting by TSX - PR Newswire (press release)
www.prnewswire.com - February 18 at 8:14 AM
BioAmber Inc. Receives Notice of Delisting by TSXBioAmber Inc. Receives Notice of Delisting by TSX
finance.yahoo.com - February 16 at 8:13 AM
Bioamber (BIOA) Upgraded to Hold by ValuEngineBioamber (BIOA) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - February 14 at 11:42 PM
BioAmber Inc. Receives Notice of Delisting Review by TSXBioAmber Inc. Receives Notice of Delisting Review by TSX
finance.yahoo.com - February 14 at 9:18 AM
Bioamber (BIOA) Stock Rating Lowered by Zacks Investment ResearchBioamber (BIOA) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - February 13 at 7:00 PM
BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public OfferingBioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering
finance.yahoo.com - February 9 at 3:50 PM
BRIEF-Bioamber Inc Announces Pricing Of US$10 Mln Underwritten Public OfferingBRIEF-Bioamber Inc Announces Pricing Of US$10 Mln Underwritten Public Offering
www.reuters.com - February 6 at 8:49 AM
Is BioAmber Inc (NYSE:BIOA) A Financially Sound Company?Is BioAmber Inc (NYSE:BIOA) A Financially Sound Company?
finance.yahoo.com - February 6 at 8:49 AM
BioAmber Inc. announces underwritten offeringBioAmber Inc. announces underwritten offering
finance.yahoo.com - February 6 at 8:49 AM
BioAmber Inc. Announces Pricing of US$10 Million Underwritten Public OfferingBioAmber Inc. Announces Pricing of US$10 Million Underwritten Public Offering
finance.yahoo.com - February 6 at 8:49 AM
Bioamber (BIOA) Downgraded by Zacks Investment Research to "Sell"Bioamber (BIOA) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - January 31 at 6:40 PM
Bio-Succinic Acid Demonstrates Substantial Benefits Toward Growth Performance in Animal Feed Commercial TrialBio-Succinic Acid Demonstrates Substantial Benefits Toward Growth Performance in Animal Feed Commercial Trial
finance.yahoo.com - January 29 at 9:10 AM
BRIEF-Bioamber Restructures Its Credit Facility With Its Senior Lenders - ReutersBRIEF-Bioamber Restructures Its Credit Facility With Its Senior Lenders - Reuters
www.reuters.com - January 27 at 3:42 PM
BioAmber (BIOA) Canadian Subsidiary Restructures Credit Facility - StreetInsider.comBioAmber (BIOA) Canadian Subsidiary Restructures Credit Facility - StreetInsider.com
www.streetinsider.com - January 27 at 3:42 PM
Contrasting Chemtura (CHMT) and Bioamber (BIOA)Contrasting Chemtura (CHMT) and Bioamber (BIOA)
www.americanbankingnews.com - January 27 at 11:26 AM
BioAmber restructures its credit facility with its senior lendersBioAmber restructures its credit facility with its senior lenders
finance.yahoo.com - January 26 at 8:43 AM
Global Renewable Chemicals IndustryGlobal Renewable Chemicals Industry
www.bizjournals.com - January 19 at 9:52 AM
Zacks: Analysts Set $6.50 Price Target for Bioamber Inc (BIOA)Zacks: Analysts Set $6.50 Price Target for Bioamber Inc (BIOA)
www.americanbankingnews.com - January 12 at 9:32 AM
Bioamber (BIOA) & AdvanSix (ASIX) Critical AnalysisBioamber (BIOA) & AdvanSix (ASIX) Critical Analysis
www.americanbankingnews.com - January 9 at 11:16 PM
Bioamber (BIOA) Raised to Hold at Zacks Investment ResearchBioamber (BIOA) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 9 at 5:40 PM
North America organic acid market is projected to reach $ 3,043.5 million by 2026North America organic acid market is projected to reach $ 3,043.5 million by 2026
www.bizjournals.com - January 5 at 8:23 AM
Bioamber (BIOA) Downgraded by Zacks Investment ResearchBioamber (BIOA) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 3 at 12:06 AM
With A -20.78% Earnings Drop Lately, Did BioAmber Inc (NYSE:BIOA) Underperform Its Industry?With A -20.78% Earnings Drop Lately, Did BioAmber Inc (NYSE:BIOA) Underperform Its Industry?
finance.yahoo.com - January 2 at 3:31 PM
Stock Review for Chemicals Investors -- BioAmber, Air Products and Chemicals, Celanese, and Eastman Chemical ... - PR Newswire (press release)Stock Review for Chemicals Investors -- BioAmber, Air Products and Chemicals, Celanese, and Eastman Chemical ... - PR Newswire (press release)
www.prnewswire.com - December 18 at 8:04 AM
 Brokerages Set $6.50 Price Target for Bioamber Inc (BIOA) Brokerages Set $6.50 Price Target for Bioamber Inc (BIOA)
www.americanbankingnews.com - December 13 at 9:18 PM
Bioamber Inc (BIOA) Director Acquires $17,200.00 in StockBioamber Inc (BIOA) Director Acquires $17,200.00 in Stock
www.americanbankingnews.com - December 4 at 9:32 PM
Bioamber (BIOA) Rating Lowered to Strong Sell at ValuEngineBioamber (BIOA) Rating Lowered to Strong Sell at ValuEngine
www.americanbankingnews.com - December 3 at 10:04 PM
Global Tetrahydrofuran (THF) Markets, 2024: Increasing Focus on Green Chemistry: A Strong Growth Driver for 2-MeTHFGlobal Tetrahydrofuran (THF) Markets, 2024: Increasing Focus on Green Chemistry: A Strong Growth Driver for 2-MeTHF
www.finanznachrichten.de - November 23 at 3:45 PM
Contrasting Trinseo (TSE) & BioAmber (BIOA)Contrasting Trinseo (TSE) & BioAmber (BIOA)
www.americanbankingnews.com - November 23 at 3:12 AM
 BioAmber Inc. (BIOA) Given Consensus Recommendation of "Buy" by Analysts BioAmber Inc. (BIOA) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 17 at 7:12 PM
Short Interest in BioAmber Inc. (BIOA) Expands By 111.4%Short Interest in BioAmber Inc. (BIOA) Expands By 111.4%
www.americanbankingnews.com - November 16 at 1:34 AM
Edited Transcript of BIOA earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of BIOA earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 11 at 9:26 PM
BioAmber Inc. (BIOA) Stock Rating Reaffirmed by Cowen and CompanyBioAmber Inc. (BIOA) Stock Rating Reaffirmed by Cowen and Company
www.americanbankingnews.com - November 11 at 10:22 AM
HC Wainwright Reiterates "Buy" Rating for BioAmber Inc. (BIOA)HC Wainwright Reiterates "Buy" Rating for BioAmber Inc. (BIOA)
www.americanbankingnews.com - November 8 at 11:10 PM
BioAmber Announces Third Quarter 2017 Financial Results - PR Newswire (press release)BioAmber Announces Third Quarter 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - November 8 at 7:08 PM
BioAmbers (BIOA) CEO Rick Eno on Q3 2017 Results - Earnings Call TranscriptBioAmber's (BIOA) CEO Rick Eno on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 12:21 AM
BioAmber Announces Third Quarter 2017 Financial ResultsBioAmber Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 7 at 7:18 PM
BioAmber reports 3Q lossBioAmber reports 3Q loss
finance.yahoo.com - November 7 at 7:18 PM
Valvoline (VVV) versus BioAmber (BIOA) Financial SurveyValvoline (VVV) versus BioAmber (BIOA) Financial Survey
www.americanbankingnews.com - November 7 at 3:28 AM
Pre-market Technical Pulse on Chemicals Stocks -- BioAmber, Celanese, DowDuPont, and Eastman ChemicalPre-market Technical Pulse on Chemicals Stocks -- BioAmber, Celanese, DowDuPont, and Eastman Chemical
www.bizjournals.com - October 30 at 10:41 PM
BioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial ResultsBioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial Results
finance.yahoo.com - October 27 at 6:54 PM
BioAmber Inc. (BIOA) Set to Announce Earnings on WednesdayBioAmber Inc. (BIOA) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 6:30 AM
BioAmber President and COO Steps Down - PR Newswire (press release)BioAmber President and COO Steps Down - PR Newswire (press release)
www.prnewswire.com - October 25 at 4:41 AM
BioAmber President and COO Steps DownBioAmber President and COO Steps Down
finance.yahoo.com - October 24 at 6:33 PM
Reviewing BioAmber (BIOA) & Valvoline (VVV)Reviewing BioAmber (BIOA) & Valvoline (VVV)
www.americanbankingnews.com - October 23 at 4:32 PM
BioAmber Inc. (BIOA) Short Interest Up 42.9% in SeptemberBioAmber Inc. (BIOA) Short Interest Up 42.9% in September
www.americanbankingnews.com - October 17 at 1:04 AM
How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?
finance.yahoo.com - October 10 at 5:51 PM
How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?How Does Investing In BioAmber Inc (BIOA) Impact Your Portfolio?
finance.yahoo.com - October 10 at 5:51 PM
Reviewing Innospec (IOSP) & BioAmber (BIOA)Reviewing Innospec (IOSP) & BioAmber (BIOA)
www.americanbankingnews.com - September 19 at 12:48 AM
Form 8-K BioAmber Inc. For: Sep 11 - StreetInsider.comForm 8-K BioAmber Inc. For: Sep 11 - StreetInsider.com
www.streetinsider.com - September 16 at 4:15 PM

SEC Filings

Bioamber (NYSE:BIOA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bioamber (NYSE:BIOA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bioamber (NYSE BIOA) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.